Literature DB >> 9426443

Transformation of primary chick embryo fibroblasts by Marek's disease virus.

C Buranathai1, J Rodriguez, C Grose.   

Abstract

Marek's disease virus (MDV) is an alphaherpesvirus, which can mediate the malignant transformation of lymphocytes to form lymphomas in chickens. In this study, we demonstrate that MDV can transform primary chick embryo fibroblasts (CEF). The cell line derived from primary CEF infected with the GA strain of MDV was called CEM(MDV). The fibroblast nature of CEM(MDV) was verified by absence of cytokeratin type II. The CEM(MDV) phenotype differed from either primary CEF or MDV-infected CEF. CEM(MDV) were extensively vacuolated, with unusual multilamellar structures in the cytoplasm, The nuclei were considerably larger than those in primary CEF and were uniformly positive for proliferating cell nuclear antigen. The cell line was subcultured for more than 10 generations; however, CEM(MDV) did not support a fully productive MDV infection, because complete nucleocapsids were not detected and infectivity assays showed that cell line produced no infectious virus. PCR analyses demonstrated that this cell line carried both polypeptide 38 (pp38) and Meq DNA, MDV-specific genes associated with transformation. In addition, examination by laser scanning confocal microscopy revealed that CEM(MDV) constitutively produced MDV MEQ protein in nuclei and pp38 as well as glycoprotein B in the cytoplasm and on the plasma membrane. Growth in soft agar assay demonstrated that CEM(MDV) formed colonies, similar to HeLa and human melanoma cells. Retroviral insertion was not detected in DNA from the CEM(MDV) line.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9426443     DOI: 10.1006/viro.1997.8854

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  Transactivation of latent Marek's disease herpesvirus genes in QT35, a quail fibroblast cell line, by herpesvirus of turkeys.

Authors:  T Yamaguchi; S L Kaplan; P Wakenell; K A Schat
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

2.  Marek's disease virus Meq transforms chicken cells via the v-Jun transcriptional cascade: a converging transforming pathway for avian oncoviruses.

Authors:  Alon M Levy; Oren Gilad; Liang Xia; Yoshihiro Izumiya; Jonathan Choi; Anya Tsalenko; Zohar Yakhini; Richard Witter; Lucy Lee; Carol J Cardona; Hsing-Jien Kung
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

3.  Marek's disease virus phosphorylated polypeptide pp38 alters transcription rates of mitochondrial electron transport and oxidative phosphorylation genes.

Authors:  Michael S Piepenbrink; Xinhui Li; Priscilla H O'Connell; Karel A Schat
Journal:  Virus Genes       Date:  2009-05-27       Impact factor: 2.332

4.  Molecular indications for in vivo integration of the avian leukosis virus, subgroup J-long terminal repeat into the Marek's disease virus in experimentally dually-infected chickens.

Authors:  I Davidson; R Borenshtain; H J Kung; R L Witter
Journal:  Virus Genes       Date:  2002-03       Impact factor: 2.332

5.  The Meq oncoprotein of Marek's disease virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  Xufang Deng; Xiangdong Li; Yang Shen; Yafeng Qiu; Zixue Shi; Donghua Shao; Yamei Jin; Hongjun Chen; Chan Ding; Li Li; Puyan Chen; Zhiyong Ma
Journal:  Virol J       Date:  2010-11-26       Impact factor: 4.099

Review 6.  Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.

Authors:  J L Liu; H J Kung
Journal:  Virus Genes       Date:  2000       Impact factor: 2.198

7.  Structural characteristics and antiviral activity of multiple peptides derived from MDV glycoproteins B and H.

Authors:  Xiaojia Wang; Xiaojing Chi; Ming Wang
Journal:  Virol J       Date:  2011-04-25       Impact factor: 4.099

8.  Microsatellite instability in Marek's disease virus infected primary chicken embryo fibroblasts.

Authors:  Zhenlei Zhou; Dawei Yao; Yan Qiu; Deji Yang
Journal:  Virol J       Date:  2012-09-11       Impact factor: 4.099

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.